BRIEF-Terns Pharmaceuticals Q1 Net Income USD -23.908 Million

Reuters
09 May
BRIEF-Terns Pharmaceuticals Q1 Net Income USD -23.908 Million

May 08 (Reuters) - Terns Pharmaceuticals Q1 operating expenses USD 27.427 million.

  • Q1 basic EPS USD -0.26
  • Q1 income from operations USD -27.427 million
  • Q1 pretax profit USD -23.82 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10